PSA Testing Explained

PSA screening remains one of the most debated areas in men's health. Any source presenting it as a simple yes-or-no issue leaves out important context. This guide explains what PSA actually measures, why the debate exists, what raises a reading besides cancer, how to interpret a result, and — importantly for anyone taking a prostate supplement — why you must disclose it before testing.

What PSA Actually Is

Prostate-specific antigen is an enzyme produced by prostate epithelial cells. Its normal job is to liquefy semen after ejaculation, keeping sperm mobile. Most of it stays in the prostate and seminal fluid, but a small amount leaks into the bloodstream, and that is what the test measures.

The word to focus on is prostate-specific, not cancer-specific. PSA tells you something is happening in the prostate. It does not tell you what. Anything disrupting normal prostate architecture — benign growth, inflammation, infection, physical pressure — can increase leakage into the blood. Cancer is one cause among several.

PSA circulates in two forms: bound to proteins, and unbound or "free". The ratio between them carries additional information, because cancer tends to produce proportionally less free PSA. This is why a doctor may order a free-to-total ratio when a total PSA sits in an ambiguous range.

Why the Screening Debate Exists

The tension is real and worth understanding rather than glossing over.

The case for screening

Prostate cancer is common, and in its early stages it is typically asymptomatic — meaning symptoms are not a reliable early-warning system. When caught early, treatment outcomes are generally good. PSA testing detects some aggressive cancers before they spread, and population-level evidence suggests screening reduces prostate cancer mortality to some degree.

The case against routine screening

Many prostate cancers grow so slowly they would never have caused symptoms or shortened life. Detecting them leads to biopsies — which carry infection and bleeding risk — and often to treatment with genuine side effects including incontinence and erectile dysfunction. This is overdiagnosis and overtreatment, and it is not a hypothetical concern.

Where the consensus landed

Most major guidelines now recommend shared decision-making: rather than screening every man automatically or discouraging it entirely, doctors should discuss the benefits and harms so the man can decide. Broadly the conversation is recommended from around age 50 for average-risk men, and earlier — around 40 to 45 — for men with a family history of prostate cancer or of African ancestry, both of which raise baseline risk.

Active surveillance has also changed the calculus considerably. Low-risk cancers are increasingly monitored rather than immediately treated, which reduces the overtreatment problem that drove much of the original criticism.

What Raises PSA Besides Cancer

This list is the single most useful thing to know before you get tested, because it explains why an elevated result is a prompt for more information rather than a diagnosis.

• Benign prostatic hyperplasia. More prostate tissue produces more PSA. This is the most common reason for a raised reading in older men.
• Prostatitis or urinary infection. Inflammation can raise PSA substantially, sometimes dramatically. Doctors often re-test after treating an infection.
• Recent ejaculation. Can elevate PSA for up to 48 hours. Abstain for two days before testing.
• Vigorous cycling. Perineal pressure can raise readings. Avoid long rides in the 48 hours before a test.
• Digital rectal examination. Can produce a modest rise. If both are being done, blood should ideally be drawn first.
• Catheterization, cystoscopy or biopsy. All raise PSA, sometimes for weeks.
• Age. PSA rises naturally with age, which is why age-specific reference ranges exist.

And what lowers it

5-alpha-reductase inhibitors (finasteride, dutasteride) roughly halve PSA. A man on finasteride with a PSA of 2.0 effectively has an untreated equivalent around 4.0, and clinicians double the reading to interpret it. Obesity can also modestly lower PSA through blood volume dilution.

The Supplement Issue Nobody Mentions

This deserves its own section, because it directly affects anyone reading a prostate supplement website.

Several ingredients in prostate formulas affect 5-alpha-reductase — the same enzyme finasteride blocks, if far more weakly. Saw palmetto and beta-sitosterol both do. And a randomized placebo-controlled trial of beta-sitosterol-enriched saw palmetto oil found it significantly lowered PSA alongside improving symptoms (PMID 32620155).

The implication is serious. If a supplement modestly lowers your PSA, a reading that would otherwise have prompted further investigation might instead look reassuring. That is a false negative created by something you took with good intentions and did not think to mention.

So: always tell your doctor what supplements you take before a PSA test. This applies to Prostate 911 and to every other prostate formula containing saw palmetto, beta-sitosterol, pygeum or nettle. It is not a reason to avoid supplements. It is a reason to disclose them, so your result is read in context. Doctors deal with this routinely once they know.

Interpreting a Result

There is no single PSA number that means cancer and no single number that guarantees safety, which frustrates men wanting a clean answer.

The traditional threshold of 4.0 ng/mL is now understood as a rough guide rather than a hard line. Cancers occur below it and most men above it do not have cancer. Several other factors carry more information than the raw number:

• PSA velocity — how fast it is changing over time. A rising trend is more concerning than a single stable elevated value, which is why a baseline in your early fifties is so useful.
• PSA density — the level relative to prostate volume. A high PSA from a very large benign prostate is less concerning than the same figure from a small one.
• Free-to-total ratio — a lower proportion of free PSA raises suspicion.
• Age-specific ranges — what is normal at 45 differs from what is normal at 75.
• Digital rectal exam findings — a hard or irregular area changes the picture regardless of the number.

If a result is elevated, the next step is usually not an immediate biopsy. Repeat testing, treating any infection, MRI imaging, or newer risk-calculator tools are all commonly used to decide whether biopsy is warranted. MRI before biopsy in particular has meaningfully reduced unnecessary procedures in recent years.

How to Prepare for a PSA Test

1. Abstain from ejaculation for 48 hours beforehand.
2. Avoid vigorous cycling for 48 hours beforehand.
3. Postpone if you have a urinary infection or are being treated for one — wait until it has resolved.
4. Have blood drawn before any rectal examination, not after.
5. Disclose all supplements and medications, particularly prostate formulas, finasteride or dutasteride.
6. Use the same laboratory where possible, since assay differences can produce small variations between labs.
7. Ask what the plan is before the test, not after. Knowing in advance what an elevated result would lead to prevents reactive decisions.

Making the Decision

There is no universally correct answer to whether you should be screened, which is precisely why the guidelines describe a conversation rather than a rule.

Factors that push toward testing: family history of prostate cancer, African ancestry, being in your fifties or sixties with a reasonable life expectancy, and a personal preference for finding things early even at the cost of some uncertainty.

Factors that push away: advanced age with significant other health conditions where treatment would be unlikely to extend life, and a strong personal preference against the anxiety and intervention cascade that an ambiguous result can trigger.

What is not a good reason to skip the conversation is discomfort or vagueness. Whatever you decide, having a baseline in your early fifties makes every subsequent result far more interpretable, and deciding deliberately is better than defaulting by avoidance. Our prostate health after 50 guide covers the wider set of questions worth asking your doctor.

One final point worth stating plainly: PSA testing screens for prostate cancer. It is not a test for BPH, and a normal PSA does not mean your urinary symptoms are nothing. The two are separate conversations, and both are worth having.